Insights provides context and perspective about key pharmacy trends and issues

Public Policy
With a slate of bills trying to tackle rising drug prices, CVS Health advocates for those that could help increase competition and lower drug prices; others may limit private sector choice... More
Commentary
Public Policy
Our perspective offered to Congress on solutions and policies that can help bring escalating drug prices under control. More
Commentary
Public Policy
Solutions such as POS rebates and $0 copay drug lists can lower costs for plans and consumers, while a one-size-fits-all approach could lead to unintended consequences, and higher costs. More
Briefing
Twisting mountain road in the Swiss alps
Public Policy
Proposed HHS rule would eliminate rebates PBMs negotiate for Part D plans and MCOs, and may eventually affect all plans. Manufacturers would retain 15% of rebates currently negotiated and... More
Briefing
Icon of female pharmacist
Public Policy
As health care costs continue to rise and demand for primary care providers outpaces supply, pharmacists are increasingly on the front lines of care utilizing their clinical skills to help... More
Commentary
Icon of pill bottle and calendar
Public Policy
As our nation fights an opioid epidemic, policies designed to balance access and appropriate utilization can help prevent and reduce misuse and abuse. Concerted effort at the state and... More
Commentary
Icon of hammer, gavel and doctor
Public Policy
This fall, as state legislatures reconvene, they’ll consider dozens of bills aimed at restricting PBM tools like utilization management that help control costs while ensuring appropriate... More
Commentary
Icon of court building
Public Policy
With all efforts so far to repeal and replace the Affordable Care Act having failed, the future of health care reform is uncertain. More
Commentary
Icon of documents with a checkmark symbol
Public Policy
A focus on prioritizing generic review and fostering competition could help in the battle against sky-rocketing prescription drug costs. More
Commentary
Icon of court building
Public Policy
Lowering out-of-pocket consumer costs, ending manipulation and abuse of FDA regulations, and fostering greater competition can help lower high prescription drug costs. More
Commentary